This article explains when and how to safely restart Saxenda, what to discuss with your GP, and the clinical considerations that determine whether restarting is appropriate for you
To address this growing health concern, the ReadyRx Glutathione Injection Program offers a cutting-edge pharmaceutical solution
Other side effects of both medications include dry mouth and constipation
The European regulator first launched its investigation into the potential suicidality risk associated with the medications in July 2023
These studies consistently report favourable renal outcomes (e.g., eGFR, macroalbuminuria, or serum creatinine levels) with GLP-1 receptor agonists
Both the semaglutide and tirzepatide shortages that made compounding legally available were declared resolved in 2024 and 2025, the compounding wind-down deadlines have passed, and in April 2026 the FDA proposed closing the remaining legal pathway entirely